22157.jpg
Global Microbiological Testing of Water Market Analysis Report 2020-2027: Heavy Initial Investment Costs Restraining Market Growth
May 07, 2021 04:03 ET | Research and Markets
Dublin, May 07, 2021 (GLOBE NEWSWIRE) -- The "Microbiological Testing of Water Market Analysis, By Pathogen Type, By Water Type, By Type, By Industry, Forecasts To 2027" report has been added to...
Adverum_Primary_Medium.png
Adverum Reports First Quarter 2021 Results
May 06, 2021 16:00 ET | Adverum Biotechnologies, Inc.
REDWOOD CITY, Calif., May 06, 2021 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases,...
Cytokinetics_Logo_RGB (1).jpg
Cytokinetics Reports First Quarter 2021 Financial Results
May 06, 2021 16:00 ET | Cytokinetics, Incorporated
Secondary Analysis from GALACTIC-HF to be Presented in Late Breaking Clinical Trial Session at ACC.21 Company Plans to Submit NDA for Omecamtiv Mecarbil following Recent Meeting with FDA Results...
Surrozen Logo FINAL Large-1.png
Surrozen Strengthens Board of Directors with Appointments of Mace Rothenberg, M.D., and Christopher Chai
May 06, 2021 08:00 ET | Surrozen, Inc.
SOUTH SAN FRANCISCO, Calif., May 06, 2021 (GLOBE NEWSWIRE) -- Surrozen Inc., a biotechnology company discovering and developing drug candidates to selectively modulate the Wnt pathway, today...
Cytokinetics_Logo_RGB (1).jpg
Cytokinetics Announces Start of Open-Label Extension Study for Patients Completing REDWOOD-HCM
May 06, 2021 07:30 ET | Cytokinetics, Incorporated
SOUTH SAN FRANCISCO, Calif., May 06, 2021 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the first site has been activated to enroll patients in REDWOOD-HCM OLE,...
logo_ProQR-150x150.png
ProQR Announces First Quarter 2021 Operating and Financial Results
May 06, 2021 07:00 ET | ProQR Therapeutics N.V.
Phase 2/3 pivotal Illuminate trial of sepofarsen for LCA10 enrollment complete with top-line data anticipated in H1 2022Positive data reported from the Phase 1/2 clinical trial of QR-421a for the...
Madrigal logo.jpg
Madrigal Pharmaceuticals Reports 2021 First Quarter Financial Results and Highlights
May 06, 2021 06:50 ET | Madrigal Pharmaceuticals, Inc.
WEST CONSHOHOCKEN, Pa., May 06, 2021 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) announced today its first quarter 2021 financial results and highlights. “We expect several...
Sana_Logo_RGB-72_Blue.png
Sana Biotechnology Reports First Quarter 2021 Financial Results and Business Updates
May 05, 2021 16:05 ET | Sana Biotechnology, Inc
Presented key proof of concept data for multiple platforms at AACR 2021 Q1 2021 cash position of $981.9 million SEATTLE, May 05, 2021 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a...
lumos.png
Lumos Pharma Reports First Quarter 2021 Financial Results and Provides Clinical and Corporate Updates
May 05, 2021 16:01 ET | Lumos Pharma, Inc.
Newly released PK/PD data from prior study in PGHD support endogenous LUM-201 MOA and use of Predictive Enrichment Markers (PEMs) to identify patients likely to respond to LUM-201 Data presented...
Cytokinetics_Logo_RGB (1).jpg
Cytokinetics to Hold Annual Meeting of Stockholders
May 05, 2021 16:00 ET | Cytokinetics, Incorporated
SOUTH SAN FRANCISCO, Calif., May 05, 2021 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that its Annual Meeting of Stockholders will be held on Wednesday, May 12,...